Document Detail


Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion.
MedLine Citation:
PMID:  12225717     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: The goal of this study was to identify the factors responsible for embolic complications of direct current (DC) cardioversion of atrial arrhythmias. BACKGROUND: Direct current cardioversion of atrial fibrillation (AF) carries a risk of thromboembolism, which is reduced, but not eliminated, by anticoagulation. The risk of embolism after conversion of atrial flutter is believed to be lower. No series to date has included enough patients receiving anticoagulants or enough patients with atrial flutter to estimate the risk in these groups. METHODS: We reviewed the case records of 1,950 patients who underwent 2,639 attempts at DC cardioversion. RESULTS: Cardioversion was performed within two days of the apparent onset of the arrhythmia in 443 episodes, 352 without subsequent prolonged anticoagulation with one embolic complication. Cardioversion was preceded by warfarin therapy for > or = 3 weeks in 1,932 instances. No embolic complication occurred in 779 attempts performed with an international normalized ratio (INR) of > or = 2.5 (95% confidence limits 0% to 0.48%). Of 756 cases in which the INR was <2.5 or was not measured before conversion, nine were complicated by thromboembolism. Embolism was significantly more common at an INR of 1.5 to 2.4 than at an INR > or = 2.5 (0.93% vs. 0%, p = 0.012). The incidence of embolism after conversion of atrial flutter or tachycardia was similar to that after cardioversion of AF (0.72% vs. 0.46%, p = NS). CONCLUSIONS: The INR should be > or = 2.5 at the time of cardioversion if the duration of AF is uncertain or >2 days. Cardioversion of atrial flutter presents similar risks and requires similar anticoagulation.
Authors:
Mark M Gallagher; Brian J Hennessy; Nils Edvardsson; Ceara M Hart; Muriel S Shannon; Owen A Obel; Naab M Al-Saady; A John Camm
Related Documents :
17490437 - Randomized comparison between open irrigation technology and intracardiac-echo-guided e...
15001907 - Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: ana...
19096977 - Short-term ecg for out of hospital detection of silent atrial fibrillation episodes.
16831567 - Postoperative recurrence in hepatocellular carcinoma: comparison between percutaneous e...
10888087 - Mid-term follow up of mitral valve reconstruction due to active infective endocarditis.
23341837 - Incomplete revascularization in the drug eluting stent era permits meaningful long-term...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  40     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2002 Sep 
Date Detail:
Created Date:  2002-09-12     Completed Date:  2002-09-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  926-33     Citation Subset:  AIM; IM    
Affiliation:
Department of Cardiological Sciences, St. George's Hospital Medical School, London, United Kingdom. mm.gallagher@virgin.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / administration & dosage*
Atrial Fibrillation / therapy*
Atrial Flutter / therapy*
Electric Countershock / adverse effects*,  methods
Embolism / etiology*
Female
Humans
Male
Middle Aged
Warfarin / administration & dosage
Chemical
Reg. No./Substance:
0/Anticoagulants; 81-81-2/Warfarin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irreg...
Next Document:  Relationship between obesity, insulin resistance, and coronary heart disease risk.